LB992 NTX-2009, a novel charged sodium channel blocker has significant anti-inflammatory activity in an atopic dermatitis model and produces sustained inhibition of chloroquine-induced itch
Ellis, J., Chaumeron, S., LaVigne, K., Lipp, M., Malekiani, A., Cole, B.M.
Published in Journal of investigative dermatology (01.08.2022)
Published in Journal of investigative dermatology (01.08.2022)
Get full text
Journal Article
15P Efficacy of cabozantinib after immune checkpoint inhibition in a syngeneic tumor model
Rolland, S., Klinz, S.G., Chaumeron, S., Meyer-Losic, F., Hillairet de Boisferon, M.
Published in Annals of oncology (01.03.2020)
Published in Annals of oncology (01.03.2020)
Get full text
Journal Article
Immunomodulatory activity of two new aza alkyl phospholipid antineoplastic drugs
Pignol, B, Chaumeron, S, Coulomb, H, Maisonnet, T, Vandamme, B, Broquet, C, Mencia-Huerta, J M, Braquet, P
Published in Anti-cancer drugs (01.12.1992)
Published in Anti-cancer drugs (01.12.1992)
Get more information
Journal Article
280 POSTER Targeting CDC25 phosphatases in cancer therapy
Ducommun, B., Prevost, G., Cazales, M., Brezak, M., Boutros, R., Contour-Galcera, M., Chaumeron, S., Quaranta, M.
Published in European journal of cancer supplements (01.11.2006)
Published in European journal of cancer supplements (01.11.2006)
Get full text
Journal Article
Modulation of the priming effects of platelet-activating factor on the release of interleukin-1 from lipopolysaccharide-stimulated rat spleen macrophages
Pignol, B, Henane, S, Chaumeron, S, Mencia-Huerta, J M, Braquet, P
Published in Journal of lipid mediators (1990)
Get more information
Published in Journal of lipid mediators (1990)
Journal Article